Abstract: The invention relates to a method of increasing the resistance to one or more penetrating pathogen(s) in a monocotyledonous or dicotyledonous plant or a part of a plant, for example in an organ, tissue, a cell or a part of a plant cell, for example in an organell, wherein a DNA sequence which codes for an armadillo repeat ARM1 protein and which mediates an increased pathogen resistance, preferably an increased resistance to fungal pathogens, is increased into, and expressed in, the plant or plant cell; or wherein an endogenous DNA sequence which codes for an armadillo repeat ARM1 protein and which mediates an increased pathogen resistance, preferably an increased resistance to fungal pathogens, is increased in the plant or plant cell in comparison with the original, or wild-type, plant, or wherein the endogenous gene sequence or preferably the 5?-untranslated region (5?UTR) is modified in comparison with the original sequence.

Abstract: This invention relates to co-crystals and salts of CCR3 inhibitors of formula 1, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases related with the CCR3-receptor.

Abstract: The present invention concerns highly swellable absorption mediums with a reduced caking tendency at high humidity and/or high temperatures, wherein a swellable polymer is coated with a non-ionic, nitrogen-containing surfactant and optionally a Lewis acid and then reacted by heating.

Abstract: The present invention relates to a method of preparing compounds of general formula I wherein m, n, R1 and R2 are defined as mentioned hereinafter, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases.

Abstract: The invention relates to a method of generating or increasing a pathogen resistance in plants by reducing the expression of at least one stomatin polypeptide or a functional equivalent thereof. The invention relates to novel nucleic acid sequences coding for a Hordeum vulgare stomatin (HvSTM1) polynucleotide and describes homologous sequences (STM1) thereof, and to their use in methods for obtaining a pathogen resistance in plants, and to nucleic acid constructs, expression cassettes and vectors which comprise these sequences and which are suitable for mediating a fungal resistance in plants. The invention furthermore relates to transgenic organisms, in particular plants, which are transformed with these expression cassettes or vectors, and to cultures, parts or transgenic propagation material derived therefrom.

Abstract: A method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure, wherein the plants, the plant propagules, the seed of the plants and/or the locus where the plants are growing or are intended to grow are treated with an effective amount of a composition comprising a) the Bacillus subtilis strain with NRRL Accession No. B-21661 or a cell-free extract thereof, and/or a mutant of this strain or extract having all the identifying characteristics of the respective strain or extract as component (I), and b) optionally at least one chemical compound as component (II), selected from the active compound groups A) to J): A) strobilurins; B) carboxamides; C) azoles; D) heterocyclic compounds; E) carbamates; F) other active substances; G) growth regulators; H) herbicides; J) insecticides.

Abstract: The present invention relates to a process for preparing compounds of general formula I wherein m, n, o, R1, R2 and R3 are defined as mentioned hereinafter, the enantiomers thereof and the diastereomers thereof, which are particularly suitable for preparing compounds of general formula II wherein m, o, R1, R2, R3 and R4 are defined as mentioned hereinafter. The compounds of general formula II have B1-antagonistic properties.

Abstract: An absorbent structure made at least in part from a superabsorbent material having a retention capacity (CRC) as determined by a Centrifuge Retention Capacity Test of at least about 25 g/g and a free swell gel bed permeability (GBP) as determined by a Free Swell Gel Bed Permeability Test of at least 575×10?9 cm2. In another embodiment, the absorbent structure is made at least in part from a superabsorbent material having a retention capacity (CRC) as determined by a Centrifuge Retention Capacity Test of at least about 25 g/g, an absorbency under load (AUL) at 0.9 psi as determined by an Absorbency Under Load Test of at least 18 and a free swell gel bed permeability (GBP) as determined by a Free Swell Gel Bed Permeability Test of at least about 350×10?9 cm2.

Abstract: A magnetic coupler arrangement that includes two quarter wave length strip patches, an input signal source, a signal splitter that splits an input signal from the input signal source into two signals and phase-shifts one of the two signals, wherein the phase-shifted signal and the non-phase-shifted signal are fed into the patches of the coupler to achieve a balanced signal configuration.

Abstract: The invention relates to the control of pathogens. Disclosed herein are methods of producing transgenic plants with increased pathogen resistance, expression vectors comprising polynucleotides encoding for functional proteins, and transgenic plants and seeds generated thereof.

Abstract: The invention relates to the control of pathogens. Disclosed herein are methods of producing transgenic plants with increased pathogen resistance, expression vectors comprising polynucleotides encoding for functional proteins, and transgenic plants and seeds generated thereof.

Abstract: A magnetic coupler arrangement that includes two quarter wave length strip patches, an input signal source, a signal splitter that splits an input signal from the input signal source into two signals and phase-shifts one of the two signals, wherein the phase-shifted signal and the non-phase-shifted signal are fed into the patches of the coupler to achieve a balanced signal configuration.

Abstract: The invention relates to a method for production of transgenic plants and/or plant cells with increased pathogenic resistance, whereby the transgenic plants or plant cells have an altered content or an altered activity of at least one actin-depolymerising factor (ADF) with relation to the wild type. The invention also relates to the use of nucleic acids, coding for at least one ADF, for the production of transgenic plants or plant cells with increased pathogenic resistance and, furthermore, nucleic acid sequences coding for an ADF.

Abstract: A system and a method for testing the ESD behaviour, wherein a circuit (7) is automatically tested at circuit diagram level in that technology-specific ESD data is provided in database (2) for each circuit component present in the circuit, without requiring complex circuit simulations, for example based on front end or back end data, by taking into account the layout.

Abstract: The invention relates to absorptive, crosslinked polymers which are based on partly neutralized, monoethylenically unsaturated monomers carrying acid groups, and have improved properties, in particular in respect of their capacity for transportation of liquids in the swollen state, and which has a high gel bed permeability and high centrifuge retention capacity.

Abstract: An absorbent structure made at least in part from a superabsorbent material having a retention capacity (CRC) as determined by a Centrifuge Retention Capacity Test of at least about 25 g/g and a free swell gel bed permeability (GBP) as determined by a Free Swell Gel Bed Permeability Test of at least 575×10?9 cm2. In another embodiment, the absorbent structure is made at least in part from a superabsorbent material having a retention capacity (CRC) as determined by a Centrifuge Retention Capacity Test of at least about 25 g/g, an absorbency under load (AUL) at 0.9 psi as determined by an Absorbency Under Load Test of at least 18 and a free swell gel bed permeability (GBP) as determined by a Free Swell Gel Bed Permeability Test of at least about 350×10?9 cm2.

Abstract: The present invention relates to a method for the production of transgenic plants and/or plant cells, respectively, with increased pathogen resistance, characterized in that a DNA sequence, which encodes a protein with the activity of a peroxidase, is inserted into the plant and expressed therein. The invention at hand also relates to the use of nucleic acids encoding a peroxidase for the production of transgenic plants, or plant cells, respectively, with increased pathogen resistance. Further, the invention at hand relates to nucleic acid sequences encoding a peroxidase of barley.

Abstract: Among other things, a process for producing an agglomerated superabsorbent polymer particle and an agglomerated superabsorbent polymer particle are disclosed. The process comprises the steps of: (A) bringing superabsorbent polymer fine particles having at least about 40 wt. %, a particle size of less than about 150 ?m into contact with a fluid comprising to more than about 10 wt. % a cross-linkable, uncrosslinked polymer based on polymerized, ethylenically unsaturated, acid group-bearing monomers or salts thereof; and (B) cross-linking the uncrosslinked polymer by heating the superabsorbent polymer fine particles and the fluid to a temperature from about 20 to about 300° C., so that the cross-linkable, uncrosslinked polymer at least partially crosslinks.

Abstract: The invention relates to absorptive, crosslinked polymers which are based on partly neutralized, monoethylenically unsaturated monomers carrying acid groups, and have improved properties, in particular in respect of their capacity for transportation of liquids in the swollen state, and which has a high gel bed permeability and high centrifuge retention capacity.

Abstract: The present invention relates to processes for preparing transformed plant cells or organisms by transforming a population of plant cells which comprises at least one marker protein having a direct or indirect toxic effect for said population, with at least one nucleic acid sequence to be inserted in combination with at least one compound, preferably a DNA construct, capable of reducing the expression, amount, activity and/or function of the marker protein, with the transformed plant cells having a growth advantage over nontransformed cells, due to the action of said compound.